Feisal Othman
About Feisal Othman
Feisal Othman is the Associate Director of Global Risk Management Strategy at Bristol Myers Squibb, with over 20 years of experience in the pharmaceutical and healthcare industry.
Title: Associate Director, Global Risk Management Strategy
Feisal Othman currently holds the position of Associate Director, Global Risk Management Strategy at Bristol Myers Squibb in the United States. In this role, he is responsible for developing and implementing risk management strategies on a global scale, leveraging his extensive experience in the pharmaceutical and healthcare industry.
Education and Expertise
Feisal Othman obtained his Pharm.D from Midwestern University, where he studied Pharmacy from 1998 to 2003. He also holds a Bachelor of Science (B.S.) degree in Biology from the University of Illinois at Chicago, completed from 1993 to 1996. His educational background provides a strong foundation in both clinical pharmacy and biological sciences, complementing his extensive professional experience in risk management and pharmacovigilance.
Work Experience at Lundbeck
Feisal Othman worked at Lundbeck in two capacities. First, from 2014 to 2017, he served as Sr. Manager, Risk Management GPV U.S. Subsequently, he was promoted to Associate Director, Risk Management Global Pharmacovigilance US, a position he held from 2017 to 2020. During his tenure at Lundbeck, Othman was based in Deerfield, Illinois, and focused on global pharmacovigilance and risk management strategies.
Career Journey at Walgreens
Feisal Othman had a long and varied career at Walgreens, starting as a Staff Pharmacist from 2002 to 2006. He then became Chief Pharmacist from 2004 to 2006, followed by roles such as Supervisor Pharmacy Services Ecommerce from 2006 to 2010, Associate Product Manager from 2010 to 2012, and Product Manager, Digital Consumer Health from 2012 to 2014. His experience at Walgreens spans clinical, e-commerce, and product management roles.
Background in Pharmacovigilance and Risk Management
With over 20 years of experience in the pharmaceutical and healthcare industry, Feisal Othman has a robust background in both clinical pharmacy and strategic risk management. He has transitioned from clinical roles to strategic positions, focusing on global pharmacovigilance and risk management strategies. His expertise is backed by his extensive work experience and educational qualifications in pharmacy and biology.